Skip to main content
Top
Published in: Pediatric Nephrology 8/2010

01-08-2010 | Original Article

High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension

Authors: Anna Wasilewska, Edyta Tenderenda, Katarzyna Taranta-Janusz, Walentyna Zoch-Zwierz

Published in: Pediatric Nephrology | Issue 8/2010

Login to get access

Abstract

The purpose of the study was to investigate serum uric acid (SUA), high-sensitivity C-reactive protein (hs-CRP) and mean platelet volume (MPV) in pre-hypertensive (PH) and hypertensive (HT) children and adolescents. The study group consisted of 80 patients aged 10–19 years subdivided into PH and HT groups according to mean daytime or night-time systolic or diastolic blood pressure (BP) levels (>90th percentile, but <95th percentile and ≥95th percentile, respectively). The control group (C) contained 25 normotensive subjects. Serum hs-CRP level was determined by a nephelometric method (Behring); platelets (PLTs) were counted, and MPV was assessed by a Coulter Analyzer MAXM. SUA was measured with an Hitachi instrument. The median SUA and hs-CRP levels in PH and HT subjects were significantly higher than those of the controls (P < 0.01) and were higher in the HT group than in the PH group (P < 0.05). An increase in SUA above 5.5 mg/dl was associated with an increase in hs-CRP [odds ratio (OR) 4.8; confidence interval (CI) 1.3–17.4; P < 0.01]. MPV values in the PH group did not differ from those of the controls (P > 0.05), but it was significantly higher in HT patients (P < 0.01). Serum hs-CRP and MPV concentrations were positively correlated with all BP measurements except night-time diastolic blood pressure (DBP). We demonstrated that, in HT children and adolescents, increased SUA with a parallel increase in hs-CRP and PLTs with MPV is observed. Although large, multicentre, prospective studies are needed to confirm this observation, hyperuricaemia seems to be associated with an increase in hs-CRP in PH and HT patients.
Literature
1.
go back to reference Backes JM, Howard PA, Moriarty PM (2004) Role of C-reactive protein in cardiovascular disease. Ann Pharmacother 38:110–118CrossRefPubMed Backes JM, Howard PA, Moriarty PM (2004) Role of C-reactive protein in cardiovascular disease. Ann Pharmacother 38:110–118CrossRefPubMed
2.
3.
go back to reference Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M (1994) Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 8:677–681PubMed Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M (1994) Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 8:677–681PubMed
4.
go back to reference Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL (2005) Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45:34–38PubMed Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL (2005) Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45:34–38PubMed
5.
go back to reference Menè P, Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 26:2085–2092CrossRefPubMed Menè P, Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 26:2085–2092CrossRefPubMed
6.
go back to reference Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ (2004) Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 66:281–287CrossRefPubMed Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ (2004) Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 66:281–287CrossRefPubMed
7.
go back to reference Rao GN, Corson MA, Berk BC (1991) Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266:8604–8608 Rao GN, Corson MA, Berk BC (1991) Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266:8604–8608
8.
go back to reference Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562CrossRefPubMed Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562CrossRefPubMed
9.
go back to reference Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742CrossRefPubMed Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742CrossRefPubMed
10.
go back to reference Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978PubMed Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978PubMed
11.
go back to reference Retnakaran R, Zinman B, Connelly PW, Harris SB, Hanley AJ (2006) Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. J Pediatr 148:176–182CrossRefPubMed Retnakaran R, Zinman B, Connelly PW, Harris SB, Hanley AJ (2006) Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. J Pediatr 148:176–182CrossRefPubMed
12.
go back to reference Kim YG, Huang XR, Suga S, Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson RJ, Lan HY (2000) Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy. Mol Med 6:837–848PubMed Kim YG, Huang XR, Suga S, Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson RJ, Lan HY (2000) Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy. Mol Med 6:837–848PubMed
13.
go back to reference Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157–161CrossRefPubMed Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157–161CrossRefPubMed
14.
go back to reference Tschöpe D, Langer E, Schauseil S, Rösen P, Kaufmann L, Gries FA (1989) Increased platelet volume—sign of impaired thrombopoiesis in diabetes mellitus. Klin Wochenschr 67:253–259CrossRefPubMed Tschöpe D, Langer E, Schauseil S, Rösen P, Kaufmann L, Gries FA (1989) Increased platelet volume—sign of impaired thrombopoiesis in diabetes mellitus. Klin Wochenschr 67:253–259CrossRefPubMed
15.
go back to reference Senaran H, Ileri M, Altinbaş A, Koşar A, Yetkin E, Oztürk M, Karaaslan Y, Kirazli S (2001) Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 24:405–408CrossRefPubMed Senaran H, Ileri M, Altinbaş A, Koşar A, Yetkin E, Oztürk M, Karaaslan Y, Kirazli S (2001) Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 24:405–408CrossRefPubMed
16.
go back to reference Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY (2004) Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 44:415–422CrossRefPubMed Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY (2004) Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 44:415–422CrossRefPubMed
17.
go back to reference van der Loo B, Martin JF (1997) Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol 10:109–123CrossRefPubMed van der Loo B, Martin JF (1997) Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol 10:109–123CrossRefPubMed
18.
go back to reference Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, Schroeder HE (2006) Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 54:292–300CrossRefPubMed Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, Schroeder HE (2006) Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 54:292–300CrossRefPubMed
20.
go back to reference Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men. The Osaka Health Survey. J Hypertens 19:1209–1215CrossRefPubMed Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men. The Osaka Health Survey. J Hypertens 19:1209–1215CrossRefPubMed
21.
go back to reference Kułaga Z, Litwin M, Zajączkowska M, Wasilewska A, Tkaczyk M, Gurzkowska G, Świąder A, Różdżyńska A, Napieralska E, Grajda A, Barwicka K, Researchers OLAF (2009) Regional differences of anthropometric parameters and arterial blood pressure in pupils aged 7–18 years. Probl Hig Epidemiol 90:32–41 Kułaga Z, Litwin M, Zajączkowska M, Wasilewska A, Tkaczyk M, Gurzkowska G, Świąder A, Różdżyńska A, Napieralska E, Grajda A, Barwicka K, Researchers OLAF (2009) Regional differences of anthropometric parameters and arterial blood pressure in pupils aged 7–18 years. Probl Hig Epidemiol 90:32–41
22.
go back to reference Nawarycz T, Ostrowska-Nawarycz L (2007) Body mass index in the school age children and youth from the city of Lodz. Pol Merkuriusz Lek 23:264–270 Nawarycz T, Ostrowska-Nawarycz L (2007) Body mass index in the school age children and youth from the city of Lodz. Pol Merkuriusz Lek 23:264–270
23.
go back to reference Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36:1072–1078PubMed Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36:1072–1078PubMed
24.
go back to reference Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184CrossRefPubMed Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184CrossRefPubMed
25.
go back to reference Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007CrossRef Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007CrossRef
26.
go back to reference Morgenstern B Z, Butani L (2004) Casual blood pressure measurement methodology. In: Portman R, Sorof J, Ingelfinger J (eds) Pediatric Hypertension, Totowa, NJ: Humana Press, pp. 77–97 Morgenstern B Z, Butani L (2004) Casual blood pressure measurement methodology. In: Portman R, Sorof J, Ingelfinger J (eds) Pediatric Hypertension, Totowa, NJ: Humana Press, pp. 77–97
27.
go back to reference Sorof J, Daniels S (2002) Obesity hypertension in children: a problem of epidemic proportions. Hypertension 40:441–447CrossRefPubMed Sorof J, Daniels S (2002) Obesity hypertension in children: a problem of epidemic proportions. Hypertension 40:441–447CrossRefPubMed
28.
go back to reference Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ (2005) Uric acid, evolution and primitive cultures. Semin Nephrol 25:3–8CrossRefPubMed Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ (2005) Uric acid, evolution and primitive cultures. Semin Nephrol 25:3–8CrossRefPubMed
29.
go back to reference Sundström J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS (2005) Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45:28–33PubMed Sundström J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS (2005) Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45:28–33PubMed
30.
go back to reference Rovda IuI, Kazakova LM, Plaksina EA (1999) Parameters of uric acid metabolism in healthy children and in patients with arterial hypertension. Pediatriia 8:19–22 Rovda IuI, Kazakova LM, Plaksina EA (1999) Parameters of uric acid metabolism in healthy children and in patients with arterial hypertension. Pediatriia 8:19–22
31.
go back to reference Jones DP, Richey PA, Alpert BS, Li R (2008) Serum uric acid and ambulatory blood pressure in children with primary hypertension. Pediatr Res 64:556–561CrossRefPubMed Jones DP, Richey PA, Alpert BS, Li R (2008) Serum uric acid and ambulatory blood pressure in children with primary hypertension. Pediatr Res 64:556–561CrossRefPubMed
32.
go back to reference Hoeschen RJ (1997) Oxidative stress and cardiovascular disease. Can J Cardiol 13:1021–1025PubMed Hoeschen RJ (1997) Oxidative stress and cardiovascular disease. Can J Cardiol 13:1021–1025PubMed
33.
go back to reference Boogaerts MA, Hammerschmidt DE, Roelant C, Verwilghen RL, Jacob HS (1983) Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost 50:576–580PubMed Boogaerts MA, Hammerschmidt DE, Roelant C, Verwilghen RL, Jacob HS (1983) Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost 50:576–580PubMed
34.
go back to reference Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, Poole-Wilson PA, Coats AJ (1998) Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 19:1814–1822CrossRefPubMed Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, Poole-Wilson PA, Coats AJ (1998) Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 19:1814–1822CrossRefPubMed
35.
go back to reference Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, Park JR, Kim SW (2003) High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 16:429–433CrossRefPubMed Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, Park JR, Kim SW (2003) High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 16:429–433CrossRefPubMed
36.
go back to reference Lande MB, Pearson TA, Vermilion RP, Auinger P, Fernandez ID (2008) Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents. Pediatrics 122:1252–1257CrossRefPubMed Lande MB, Pearson TA, Vermilion RP, Auinger P, Fernandez ID (2008) Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents. Pediatrics 122:1252–1257CrossRefPubMed
37.
go back to reference Semiz S, Rota S, Ozdemir O, Ozdemir A, Kaptanoğlu B (2008) Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents? Pediatr Int 50:419–423CrossRefPubMed Semiz S, Rota S, Ozdemir O, Ozdemir A, Kaptanoğlu B (2008) Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents? Pediatr Int 50:419–423CrossRefPubMed
38.
go back to reference Soriano-Guillén L, Hernández-García B, Pita J, Domínguez-Garrido N, Del Río-Camacho G, Rovira A (2008) High-sensitivity C-reactive protein is a good marker of cardiovascular risk In obese children and adolescents. Eur J Endocrinol 159:R1–R4CrossRefPubMed Soriano-Guillén L, Hernández-García B, Pita J, Domínguez-Garrido N, Del Río-Camacho G, Rovira A (2008) High-sensitivity C-reactive protein is a good marker of cardiovascular risk In obese children and adolescents. Eur J Endocrinol 159:R1–R4CrossRefPubMed
39.
go back to reference Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM (2003) C-reactive protein and the risk of developing hypertension. JAMA 290:2945–2951CrossRefPubMed Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM (2003) C-reactive protein and the risk of developing hypertension. JAMA 290:2945–2951CrossRefPubMed
40.
go back to reference Intengan HD, Schiffrin EL (2001) Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38:581–587CrossRefPubMed Intengan HD, Schiffrin EL (2001) Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38:581–587CrossRefPubMed
41.
go back to reference Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, Emdin M, Flacco M, Schillaci G, DE Caterina R (2008) Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res 31:2137–2146CrossRefPubMed Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, Emdin M, Flacco M, Schillaci G, DE Caterina R (2008) Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res 31:2137–2146CrossRefPubMed
42.
go back to reference Abramson JL, Lewis C, Murrah NV, Anderson GT, Vaccarino V (2006) Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol 98:649–652CrossRefPubMed Abramson JL, Lewis C, Murrah NV, Anderson GT, Vaccarino V (2006) Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol 98:649–652CrossRefPubMed
43.
go back to reference Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, Kalay N, Topsakal R (2010) Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 209:278–282CrossRefPubMed Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, Kalay N, Topsakal R (2010) Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 209:278–282CrossRefPubMed
44.
go back to reference Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, Minuz P, Manzato F, Tridente G, Lechi A (1996) Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens 14:1215–1221CrossRefPubMed Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, Minuz P, Manzato F, Tridente G, Lechi A (1996) Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens 14:1215–1221CrossRefPubMed
45.
go back to reference Bruschi G, Bruschi ME, Caroppo M, Orlandini G, Spaggiari M, Cavatorta A (1985) Cytoplasmic free [Ca2+] is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin Sci (Lond) 68:179–184 Bruschi G, Bruschi ME, Caroppo M, Orlandini G, Spaggiari M, Cavatorta A (1985) Cytoplasmic free [Ca2+] is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin Sci (Lond) 68:179–184
46.
go back to reference Erne P, Bolli P, Bürgisser E, Bühler FR (1984) Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med 310:1084–1088PubMedCrossRef Erne P, Bolli P, Bürgisser E, Bühler FR (1984) Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med 310:1084–1088PubMedCrossRef
47.
go back to reference Camilletti A, Moretti N, Giacchetti G, Faloia E, Martarelli D, Mantero F, Mazzanti L (2001) Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens 14:382–386CrossRefPubMed Camilletti A, Moretti N, Giacchetti G, Faloia E, Martarelli D, Mantero F, Mazzanti L (2001) Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens 14:382–386CrossRefPubMed
48.
go back to reference Blann AD, Lip GY, Islim IF, Beevers DG (1997) Evidence of platelet activation in hypertension. J Hum Hypertens 11:607–609CrossRefPubMed Blann AD, Lip GY, Islim IF, Beevers DG (1997) Evidence of platelet activation in hypertension. J Hum Hypertens 11:607–609CrossRefPubMed
49.
go back to reference Pathansali R, Smith NM, Bath PM (2001) Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study. Platelets 12:144–149CrossRefPubMed Pathansali R, Smith NM, Bath PM (2001) Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study. Platelets 12:144–149CrossRefPubMed
50.
go back to reference Yazici M, Kaya A, Kaya Y, Albayrak S, Cinemre H, Ozhan H (2009) Lifestyle modification decreases the mean platelet volume in prehypertensive patients. Platelets 20:58–63CrossRefPubMed Yazici M, Kaya A, Kaya Y, Albayrak S, Cinemre H, Ozhan H (2009) Lifestyle modification decreases the mean platelet volume in prehypertensive patients. Platelets 20:58–63CrossRefPubMed
51.
go back to reference Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A (2007) Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 120:245–250CrossRefPubMed Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A (2007) Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 120:245–250CrossRefPubMed
52.
go back to reference Giles C, Inglis TC (1981) Thrombocytopenia and macrothrombocytosis in gestational hypertension. Br J Obstet Gynaecol 88:1115–1119PubMed Giles C, Inglis TC (1981) Thrombocytopenia and macrothrombocytosis in gestational hypertension. Br J Obstet Gynaecol 88:1115–1119PubMed
53.
go back to reference Coban E, Yazicioglu G, Berkant Avci A, Akcit F (2005) The mean platelet volume in patients with essential and white coat hypertension. Platelets 16:435–438CrossRefPubMed Coban E, Yazicioglu G, Berkant Avci A, Akcit F (2005) The mean platelet volume in patients with essential and white coat hypertension. Platelets 16:435–438CrossRefPubMed
55.
go back to reference Dastjerdi MS, Emami T, Najafian A, Amini M (2006) Mean platelet volume measurement, EDTA or citrate? Hematology 11:317–319CrossRefPubMed Dastjerdi MS, Emami T, Najafian A, Amini M (2006) Mean platelet volume measurement, EDTA or citrate? Hematology 11:317–319CrossRefPubMed
Metadata
Title
High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension
Authors
Anna Wasilewska
Edyta Tenderenda
Katarzyna Taranta-Janusz
Walentyna Zoch-Zwierz
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 8/2010
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1513-2

Other articles of this Issue 8/2010

Pediatric Nephrology 8/2010 Go to the issue